Elsevier

The Lancet

Volume 362, Issue 9399, 6 December 2003, Pages 1936-1937
The Lancet

Correspondence
The EUROPA trial

https://doi.org/10.1016/S0140-6736(03)14974-4Get rights and content

References (5)

  • PA Fennessy et al.

    Angiotensin-converting enzyme inhibitors and atherosclerosis: relevance of animals models to human disease

    Clin Exp Pharmacol Physiol

    (1996)
  • HD White

    Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

    Lancet

    (2003)
There are more references available in the full text version of this article.

Cited by (0)

View full text